GHRL and hepatocellular carcinoma: The present study included a relatively large total number of subjects (176 CHB patients, 106 LC patients, 151 HCC patients, and 167 healthy controls) and explored the interaction between GHRL rs26311, rs27647, rs696217 and rs34911341 polymorphisms and risk of HBV-related diseases.